文献速递妇科产科

高级别浆液性卵巢癌的瘤内异质性与同源重组缺陷与预后及分子亚型相关并在治疗过程中变化

Intratumor heterogeneity and homologous recombination deficiency of high-grade serous ovarian cancer are associated with prognosis and molecular subtype and change in treatment course.
PubMed 文献 · Gynecol Oncol · 2019-11-27

研究利用TCGA的573例SNP阵列和基因表达阵列数据计算克隆性指数(CI)和杂合性缺失(LOH)评分并分类分子亚型,另取20例HGSOC患者的33份样本(含4份IDS和9份复发手术样本)。高CI组复发风险高,高LOH组预后好,高LOH/低CI组预后好;间充质亚型CI高,免疫反应亚型LOH倾向高;治疗中IDS时CI降至1,复发时升高,2例IDS时LOH评分大幅下降。

要点

  • 高CI组复发风险高,高LOH组预后好,高LOH/低CI组预后好。
  • 间充质亚型CI高,免疫反应亚型LOH评分倾向高。
  • IDS时CI降至1,复发时升高;2例IDS时LOH评分大幅下降。

核心结论

  • HGSOC中瘤内异质性与同源重组缺陷与预后相关。
  • 新辅助化疗后瘤内异质性降低,提示化疗后残留耐药克隆。

研究设计与样本

  • 获取TCGA的573份SNP阵列和基因表达阵列数据,SNP阵列计算克隆性指数(CI)和LOH评分,基因表达阵列用于分子亚型分类。
  • 另取20例HGSOC患者的33份样本,包括4份间隔减瘤术(IDS)样本和9份复发手术样本。

主要发现

  • 高CI组显示高复发风险,高LOH组显示统计学上预后好。
  • 高LOH/低CI组显示统计学上预后好。
  • 间充质亚型预后差,其CI高且差异有统计学意义;免疫反应亚型预后好,其LOH评分有高倾向。
  • 治疗过程中,IDS时(n=4)CI降至1,随后复发时(n=3)升高。
  • 2例在IDS时LOH评分大幅下降。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: High-grade serous ovarian cancers (HGSOC) are genomically characterized by homologous recombination deficiency (HRD) and TP53 mutations, which lead to intratumor heterogeneity (ITH). This study aimed to reveal the relationship between HRD, ITH and prognosis and analyze their changes during treatment. METHODS: We obtained 573 SNP array and gene expression array data from The Cancer Genome Atlas. SNP array data were processed to calculate the Clonality Index (CI) and loss of heterozygosity (LOH) scores. Gene expression array data were used for classifying molecular subtypes. Additionally, we obtained 33 samples from 20 HGSOC patients, including 4 samples from interval debulking surgery (IDS) and 9 samples from recurrent surgery. RESULTS: We divided HGSOC samples into 2 groups. The high CI group showed a high recurrent risk, and the high LOH group showed a statistically good prognosis. Combining the two factors, the high LOH/low CI group showed a statistically good prognosis. In terms of molecular subtypes, the mesenchymal subtype, which had a poor prognosis, showed a high CI with statisitically significant difference and the immunoreactive subtype, which had a good prognosis, showed a tendency to have a high LOH score. Throughout treatment, the CI decreased to one at the IDS (n = 4) and then increased at recurrence (n = 3). LOH scores greatly decreased in two cases at the IDS. CONCLUSIONS: ITH and HRD were associated with prognosis in HGSOC. ITH decreased after neoadjuvant chemotherapy, suggesting that the chemo-resistant cancer clone remains after chemotherapy.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Takaya H, Nakai H, Sakai K, et al. Intratumor heterogeneity and homologous recombination deficiency of high-grade serous ovarian cancer are associated with prognosis and molecular subtype and change in treatment course. Gynecol Oncol. 2019. PMID: 31785864. doi:10.1016/j.ygyno.2019.11.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。